Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 640pembrolizumab 570Magnetic Resonance Spectroscopy 550Carboplatin 430Cyclophosphamide 382Cisplatin 376Biopsy 364Paclitaxel 312Nivolumab 310Gemcitabine 302Radiotherapy 275Bevacizumab 243Dexamethasone 213fludarabine 209Docetaxel 193durvalumab 182atezolizumab 179Oxaliplatin 173Rituximab 168Fluorouracil 168venetoclax 167Pemetrexed 165Doxorubicin 163Radiation 161Capecitabine 161Radiosurgery 149Etoposide 138Ipilimumab 136Leucovorin 134Lenalidomide 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
gadolinium ethoxybenzyl DTPA × 90 days × Clear all
NCT04973007 2026-04-22

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

University of Colorado, Denver

Phase 4 Terminated
10 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡